Review



rabbit polyclonal antibody against zo 2  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Thermo Fisher rabbit polyclonal antibody against zo 2
    Rabbit Polyclonal Antibody Against Zo 2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against zo 2/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    rabbit polyclonal antibody against zo 2 - by Bioz Stars, 2026-03
    86/100 stars

    Images



    Similar Products

    90
    Santa Cruz Biotechnology goat polyclonal antibody against zo-2
    Downregulation of Cx43 expression disrupts GJIC and apical polarity in S1 cells. (A) Western blot (upper image) and quantitative real-time PCR (bottom graph) for Cx43 expression in S1 cells following retroviral delivery of empty vector (EV) or non-specific sequence shRNA (NSS) used as negative controls, and Cx43-specific shRNA (shRNA). Lamin B serves as loading control; n=3. Cx43 mRNA expression normalized to EV control; data represented as mean±s.e.m. (B) Fluorescence immunostaining for Cx43 (red) in S1 cells treated as indicated and cultured for 10 days in 2D or 3D conditions. Arrows indicate Cx43 foci. Graph shows the mean±s.e.m. percentages of acini that express Cx43 in each treatment condition; at least 200 acini were analyzed per condition; n=3. (C) S1 cells infected with NSS (upper panel) or Cx43 shRNA (lower panel) were cultured in 3D for 10 days and microinjected with 3% NB in 0.15 M LiCl, followed by dual fluorescence staining with streptavidin–FITC and an antibody against Cx43 (red). Merged images show the extent of NB spread within the acini; n=10 acini. (D) Dual immunostaining of acini for Cx43 (red) and β-catenin (green; indicating cell–cell limits) in S1 cells treated as indicated. The peripheral organization of cells around a hollow center (left lower panel) is considered morphologically correct. Graph shows mean±s.e.m. percentages of acini with correct morphology; at least 100 acini analyzed per condition; n=3. (E) Dual immunostaining for Cx43 (red) and ZO-1 (green) in acini formed by S1 cells treated as indicated. The arrow points to the peripheral location of ZO-1 and the asterisk indicates the central location of a cell (optical section through the middle of the acinus), illustrating abnormal morphogenesis. Graph shows mean±s.e.m. percentages of acini with apical ZO-1 staining; at least 100 acini analyzed per condition; n=3. (F) Western blots show unchanged levels of total ZO-1 expression in 10-day-old S1 acini treated as indicated. Lamin B was used as loading control. (G,H) Western blots for Cx43 and co-immunoprecipitated β-catenin (G) or <t>ZO-2</t> (H) following immunoprecipitation with Cx43 antibody in S1 acini. *P<0.05, **P<0.01, ***P<0.001; one way ANOVA, with Dunn's comparison (A,B), nonpaired t-test (D,E). Nuclei are counterstained with DAPI (blue). Scale bar: 10 µm.
    Goat Polyclonal Antibody Against Zo 2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat polyclonal antibody against zo-2/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    goat polyclonal antibody against zo-2 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology goat polyclonal antibody against zo-2 sc-8148
    Downregulation of Cx43 expression disrupts GJIC and apical polarity in S1 cells. (A) Western blot (upper image) and quantitative real-time PCR (bottom graph) for Cx43 expression in S1 cells following retroviral delivery of empty vector (EV) or non-specific sequence shRNA (NSS) used as negative controls, and Cx43-specific shRNA (shRNA). Lamin B serves as loading control; n=3. Cx43 mRNA expression normalized to EV control; data represented as mean±s.e.m. (B) Fluorescence immunostaining for Cx43 (red) in S1 cells treated as indicated and cultured for 10 days in 2D or 3D conditions. Arrows indicate Cx43 foci. Graph shows the mean±s.e.m. percentages of acini that express Cx43 in each treatment condition; at least 200 acini were analyzed per condition; n=3. (C) S1 cells infected with NSS (upper panel) or Cx43 shRNA (lower panel) were cultured in 3D for 10 days and microinjected with 3% NB in 0.15 M LiCl, followed by dual fluorescence staining with streptavidin–FITC and an antibody against Cx43 (red). Merged images show the extent of NB spread within the acini; n=10 acini. (D) Dual immunostaining of acini for Cx43 (red) and β-catenin (green; indicating cell–cell limits) in S1 cells treated as indicated. The peripheral organization of cells around a hollow center (left lower panel) is considered morphologically correct. Graph shows mean±s.e.m. percentages of acini with correct morphology; at least 100 acini analyzed per condition; n=3. (E) Dual immunostaining for Cx43 (red) and ZO-1 (green) in acini formed by S1 cells treated as indicated. The arrow points to the peripheral location of ZO-1 and the asterisk indicates the central location of a cell (optical section through the middle of the acinus), illustrating abnormal morphogenesis. Graph shows mean±s.e.m. percentages of acini with apical ZO-1 staining; at least 100 acini analyzed per condition; n=3. (F) Western blots show unchanged levels of total ZO-1 expression in 10-day-old S1 acini treated as indicated. Lamin B was used as loading control. (G,H) Western blots for Cx43 and co-immunoprecipitated β-catenin (G) or <t>ZO-2</t> (H) following immunoprecipitation with Cx43 antibody in S1 acini. *P<0.05, **P<0.01, ***P<0.001; one way ANOVA, with Dunn's comparison (A,B), nonpaired t-test (D,E). Nuclei are counterstained with DAPI (blue). Scale bar: 10 µm.
    Goat Polyclonal Antibody Against Zo 2 Sc 8148, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat polyclonal antibody against zo-2 sc-8148/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    goat polyclonal antibody against zo-2 sc-8148 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    86
    Thermo Fisher rabbit polyclonal antibody against zo 2
    Downregulation of Cx43 expression disrupts GJIC and apical polarity in S1 cells. (A) Western blot (upper image) and quantitative real-time PCR (bottom graph) for Cx43 expression in S1 cells following retroviral delivery of empty vector (EV) or non-specific sequence shRNA (NSS) used as negative controls, and Cx43-specific shRNA (shRNA). Lamin B serves as loading control; n=3. Cx43 mRNA expression normalized to EV control; data represented as mean±s.e.m. (B) Fluorescence immunostaining for Cx43 (red) in S1 cells treated as indicated and cultured for 10 days in 2D or 3D conditions. Arrows indicate Cx43 foci. Graph shows the mean±s.e.m. percentages of acini that express Cx43 in each treatment condition; at least 200 acini were analyzed per condition; n=3. (C) S1 cells infected with NSS (upper panel) or Cx43 shRNA (lower panel) were cultured in 3D for 10 days and microinjected with 3% NB in 0.15 M LiCl, followed by dual fluorescence staining with streptavidin–FITC and an antibody against Cx43 (red). Merged images show the extent of NB spread within the acini; n=10 acini. (D) Dual immunostaining of acini for Cx43 (red) and β-catenin (green; indicating cell–cell limits) in S1 cells treated as indicated. The peripheral organization of cells around a hollow center (left lower panel) is considered morphologically correct. Graph shows mean±s.e.m. percentages of acini with correct morphology; at least 100 acini analyzed per condition; n=3. (E) Dual immunostaining for Cx43 (red) and ZO-1 (green) in acini formed by S1 cells treated as indicated. The arrow points to the peripheral location of ZO-1 and the asterisk indicates the central location of a cell (optical section through the middle of the acinus), illustrating abnormal morphogenesis. Graph shows mean±s.e.m. percentages of acini with apical ZO-1 staining; at least 100 acini analyzed per condition; n=3. (F) Western blots show unchanged levels of total ZO-1 expression in 10-day-old S1 acini treated as indicated. Lamin B was used as loading control. (G,H) Western blots for Cx43 and co-immunoprecipitated β-catenin (G) or <t>ZO-2</t> (H) following immunoprecipitation with Cx43 antibody in S1 acini. *P<0.05, **P<0.01, ***P<0.001; one way ANOVA, with Dunn's comparison (A,B), nonpaired t-test (D,E). Nuclei are counterstained with DAPI (blue). Scale bar: 10 µm.
    Rabbit Polyclonal Antibody Against Zo 2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against zo 2/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    rabbit polyclonal antibody against zo 2 - by Bioz Stars, 2026-03
    86/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit polyclonals against zo-2 711400 antibody
    Downregulation of Cx43 expression disrupts GJIC and apical polarity in S1 cells. (A) Western blot (upper image) and quantitative real-time PCR (bottom graph) for Cx43 expression in S1 cells following retroviral delivery of empty vector (EV) or non-specific sequence shRNA (NSS) used as negative controls, and Cx43-specific shRNA (shRNA). Lamin B serves as loading control; n=3. Cx43 mRNA expression normalized to EV control; data represented as mean±s.e.m. (B) Fluorescence immunostaining for Cx43 (red) in S1 cells treated as indicated and cultured for 10 days in 2D or 3D conditions. Arrows indicate Cx43 foci. Graph shows the mean±s.e.m. percentages of acini that express Cx43 in each treatment condition; at least 200 acini were analyzed per condition; n=3. (C) S1 cells infected with NSS (upper panel) or Cx43 shRNA (lower panel) were cultured in 3D for 10 days and microinjected with 3% NB in 0.15 M LiCl, followed by dual fluorescence staining with streptavidin–FITC and an antibody against Cx43 (red). Merged images show the extent of NB spread within the acini; n=10 acini. (D) Dual immunostaining of acini for Cx43 (red) and β-catenin (green; indicating cell–cell limits) in S1 cells treated as indicated. The peripheral organization of cells around a hollow center (left lower panel) is considered morphologically correct. Graph shows mean±s.e.m. percentages of acini with correct morphology; at least 100 acini analyzed per condition; n=3. (E) Dual immunostaining for Cx43 (red) and ZO-1 (green) in acini formed by S1 cells treated as indicated. The arrow points to the peripheral location of ZO-1 and the asterisk indicates the central location of a cell (optical section through the middle of the acinus), illustrating abnormal morphogenesis. Graph shows mean±s.e.m. percentages of acini with apical ZO-1 staining; at least 100 acini analyzed per condition; n=3. (F) Western blots show unchanged levels of total ZO-1 expression in 10-day-old S1 acini treated as indicated. Lamin B was used as loading control. (G,H) Western blots for Cx43 and co-immunoprecipitated β-catenin (G) or <t>ZO-2</t> (H) following immunoprecipitation with Cx43 antibody in S1 acini. *P<0.05, **P<0.01, ***P<0.001; one way ANOVA, with Dunn's comparison (A,B), nonpaired t-test (D,E). Nuclei are counterstained with DAPI (blue). Scale bar: 10 µm.
    Rabbit Polyclonals Against Zo 2 711400 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonals against zo-2 711400 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rabbit polyclonals against zo-2 711400 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit polyclonal antibody against zo-2
    Downregulation of Cx43 expression disrupts GJIC and apical polarity in S1 cells. (A) Western blot (upper image) and quantitative real-time PCR (bottom graph) for Cx43 expression in S1 cells following retroviral delivery of empty vector (EV) or non-specific sequence shRNA (NSS) used as negative controls, and Cx43-specific shRNA (shRNA). Lamin B serves as loading control; n=3. Cx43 mRNA expression normalized to EV control; data represented as mean±s.e.m. (B) Fluorescence immunostaining for Cx43 (red) in S1 cells treated as indicated and cultured for 10 days in 2D or 3D conditions. Arrows indicate Cx43 foci. Graph shows the mean±s.e.m. percentages of acini that express Cx43 in each treatment condition; at least 200 acini were analyzed per condition; n=3. (C) S1 cells infected with NSS (upper panel) or Cx43 shRNA (lower panel) were cultured in 3D for 10 days and microinjected with 3% NB in 0.15 M LiCl, followed by dual fluorescence staining with streptavidin–FITC and an antibody against Cx43 (red). Merged images show the extent of NB spread within the acini; n=10 acini. (D) Dual immunostaining of acini for Cx43 (red) and β-catenin (green; indicating cell–cell limits) in S1 cells treated as indicated. The peripheral organization of cells around a hollow center (left lower panel) is considered morphologically correct. Graph shows mean±s.e.m. percentages of acini with correct morphology; at least 100 acini analyzed per condition; n=3. (E) Dual immunostaining for Cx43 (red) and ZO-1 (green) in acini formed by S1 cells treated as indicated. The arrow points to the peripheral location of ZO-1 and the asterisk indicates the central location of a cell (optical section through the middle of the acinus), illustrating abnormal morphogenesis. Graph shows mean±s.e.m. percentages of acini with apical ZO-1 staining; at least 100 acini analyzed per condition; n=3. (F) Western blots show unchanged levels of total ZO-1 expression in 10-day-old S1 acini treated as indicated. Lamin B was used as loading control. (G,H) Western blots for Cx43 and co-immunoprecipitated β-catenin (G) or <t>ZO-2</t> (H) following immunoprecipitation with Cx43 antibody in S1 acini. *P<0.05, **P<0.01, ***P<0.001; one way ANOVA, with Dunn's comparison (A,B), nonpaired t-test (D,E). Nuclei are counterstained with DAPI (blue). Scale bar: 10 µm.
    Rabbit Polyclonal Antibody Against Zo 2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against zo-2/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal antibody against zo-2 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher polyclonal antibodies against zo-1, zo-2 occludin
    Downregulation of Cx43 expression disrupts GJIC and apical polarity in S1 cells. (A) Western blot (upper image) and quantitative real-time PCR (bottom graph) for Cx43 expression in S1 cells following retroviral delivery of empty vector (EV) or non-specific sequence shRNA (NSS) used as negative controls, and Cx43-specific shRNA (shRNA). Lamin B serves as loading control; n=3. Cx43 mRNA expression normalized to EV control; data represented as mean±s.e.m. (B) Fluorescence immunostaining for Cx43 (red) in S1 cells treated as indicated and cultured for 10 days in 2D or 3D conditions. Arrows indicate Cx43 foci. Graph shows the mean±s.e.m. percentages of acini that express Cx43 in each treatment condition; at least 200 acini were analyzed per condition; n=3. (C) S1 cells infected with NSS (upper panel) or Cx43 shRNA (lower panel) were cultured in 3D for 10 days and microinjected with 3% NB in 0.15 M LiCl, followed by dual fluorescence staining with streptavidin–FITC and an antibody against Cx43 (red). Merged images show the extent of NB spread within the acini; n=10 acini. (D) Dual immunostaining of acini for Cx43 (red) and β-catenin (green; indicating cell–cell limits) in S1 cells treated as indicated. The peripheral organization of cells around a hollow center (left lower panel) is considered morphologically correct. Graph shows mean±s.e.m. percentages of acini with correct morphology; at least 100 acini analyzed per condition; n=3. (E) Dual immunostaining for Cx43 (red) and ZO-1 (green) in acini formed by S1 cells treated as indicated. The arrow points to the peripheral location of ZO-1 and the asterisk indicates the central location of a cell (optical section through the middle of the acinus), illustrating abnormal morphogenesis. Graph shows mean±s.e.m. percentages of acini with apical ZO-1 staining; at least 100 acini analyzed per condition; n=3. (F) Western blots show unchanged levels of total ZO-1 expression in 10-day-old S1 acini treated as indicated. Lamin B was used as loading control. (G,H) Western blots for Cx43 and co-immunoprecipitated β-catenin (G) or <t>ZO-2</t> (H) following immunoprecipitation with Cx43 antibody in S1 acini. *P<0.05, **P<0.01, ***P<0.001; one way ANOVA, with Dunn's comparison (A,B), nonpaired t-test (D,E). Nuclei are counterstained with DAPI (blue). Scale bar: 10 µm.
    Polyclonal Antibodies Against Zo 1, Zo 2 Occludin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal antibodies against zo-1, zo-2 occludin/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    polyclonal antibodies against zo-1, zo-2 occludin - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher polyclonal antibodies directed against zo-2, occludin, claudin-1
    Downregulation of Cx43 expression disrupts GJIC and apical polarity in S1 cells. (A) Western blot (upper image) and quantitative real-time PCR (bottom graph) for Cx43 expression in S1 cells following retroviral delivery of empty vector (EV) or non-specific sequence shRNA (NSS) used as negative controls, and Cx43-specific shRNA (shRNA). Lamin B serves as loading control; n=3. Cx43 mRNA expression normalized to EV control; data represented as mean±s.e.m. (B) Fluorescence immunostaining for Cx43 (red) in S1 cells treated as indicated and cultured for 10 days in 2D or 3D conditions. Arrows indicate Cx43 foci. Graph shows the mean±s.e.m. percentages of acini that express Cx43 in each treatment condition; at least 200 acini were analyzed per condition; n=3. (C) S1 cells infected with NSS (upper panel) or Cx43 shRNA (lower panel) were cultured in 3D for 10 days and microinjected with 3% NB in 0.15 M LiCl, followed by dual fluorescence staining with streptavidin–FITC and an antibody against Cx43 (red). Merged images show the extent of NB spread within the acini; n=10 acini. (D) Dual immunostaining of acini for Cx43 (red) and β-catenin (green; indicating cell–cell limits) in S1 cells treated as indicated. The peripheral organization of cells around a hollow center (left lower panel) is considered morphologically correct. Graph shows mean±s.e.m. percentages of acini with correct morphology; at least 100 acini analyzed per condition; n=3. (E) Dual immunostaining for Cx43 (red) and ZO-1 (green) in acini formed by S1 cells treated as indicated. The arrow points to the peripheral location of ZO-1 and the asterisk indicates the central location of a cell (optical section through the middle of the acinus), illustrating abnormal morphogenesis. Graph shows mean±s.e.m. percentages of acini with apical ZO-1 staining; at least 100 acini analyzed per condition; n=3. (F) Western blots show unchanged levels of total ZO-1 expression in 10-day-old S1 acini treated as indicated. Lamin B was used as loading control. (G,H) Western blots for Cx43 and co-immunoprecipitated β-catenin (G) or <t>ZO-2</t> (H) following immunoprecipitation with Cx43 antibody in S1 acini. *P<0.05, **P<0.01, ***P<0.001; one way ANOVA, with Dunn's comparison (A,B), nonpaired t-test (D,E). Nuclei are counterstained with DAPI (blue). Scale bar: 10 µm.
    Polyclonal Antibodies Directed Against Zo 2, Occludin, Claudin 1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal antibodies directed against zo-2, occludin, claudin-1/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    polyclonal antibodies directed against zo-2, occludin, claudin-1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit polyclonal antibodies against zo-1, zo-2, zo-3, occludin
    Downregulation of Cx43 expression disrupts GJIC and apical polarity in S1 cells. (A) Western blot (upper image) and quantitative real-time PCR (bottom graph) for Cx43 expression in S1 cells following retroviral delivery of empty vector (EV) or non-specific sequence shRNA (NSS) used as negative controls, and Cx43-specific shRNA (shRNA). Lamin B serves as loading control; n=3. Cx43 mRNA expression normalized to EV control; data represented as mean±s.e.m. (B) Fluorescence immunostaining for Cx43 (red) in S1 cells treated as indicated and cultured for 10 days in 2D or 3D conditions. Arrows indicate Cx43 foci. Graph shows the mean±s.e.m. percentages of acini that express Cx43 in each treatment condition; at least 200 acini were analyzed per condition; n=3. (C) S1 cells infected with NSS (upper panel) or Cx43 shRNA (lower panel) were cultured in 3D for 10 days and microinjected with 3% NB in 0.15 M LiCl, followed by dual fluorescence staining with streptavidin–FITC and an antibody against Cx43 (red). Merged images show the extent of NB spread within the acini; n=10 acini. (D) Dual immunostaining of acini for Cx43 (red) and β-catenin (green; indicating cell–cell limits) in S1 cells treated as indicated. The peripheral organization of cells around a hollow center (left lower panel) is considered morphologically correct. Graph shows mean±s.e.m. percentages of acini with correct morphology; at least 100 acini analyzed per condition; n=3. (E) Dual immunostaining for Cx43 (red) and ZO-1 (green) in acini formed by S1 cells treated as indicated. The arrow points to the peripheral location of ZO-1 and the asterisk indicates the central location of a cell (optical section through the middle of the acinus), illustrating abnormal morphogenesis. Graph shows mean±s.e.m. percentages of acini with apical ZO-1 staining; at least 100 acini analyzed per condition; n=3. (F) Western blots show unchanged levels of total ZO-1 expression in 10-day-old S1 acini treated as indicated. Lamin B was used as loading control. (G,H) Western blots for Cx43 and co-immunoprecipitated β-catenin (G) or <t>ZO-2</t> (H) following immunoprecipitation with Cx43 antibody in S1 acini. *P<0.05, **P<0.01, ***P<0.001; one way ANOVA, with Dunn's comparison (A,B), nonpaired t-test (D,E). Nuclei are counterstained with DAPI (blue). Scale bar: 10 µm.
    Rabbit Polyclonal Antibodies Against Zo 1, Zo 2, Zo 3, Occludin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibodies against zo-1, zo-2, zo-3, occludin/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal antibodies against zo-1, zo-2, zo-3, occludin - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Downregulation of Cx43 expression disrupts GJIC and apical polarity in S1 cells. (A) Western blot (upper image) and quantitative real-time PCR (bottom graph) for Cx43 expression in S1 cells following retroviral delivery of empty vector (EV) or non-specific sequence shRNA (NSS) used as negative controls, and Cx43-specific shRNA (shRNA). Lamin B serves as loading control; n=3. Cx43 mRNA expression normalized to EV control; data represented as mean±s.e.m. (B) Fluorescence immunostaining for Cx43 (red) in S1 cells treated as indicated and cultured for 10 days in 2D or 3D conditions. Arrows indicate Cx43 foci. Graph shows the mean±s.e.m. percentages of acini that express Cx43 in each treatment condition; at least 200 acini were analyzed per condition; n=3. (C) S1 cells infected with NSS (upper panel) or Cx43 shRNA (lower panel) were cultured in 3D for 10 days and microinjected with 3% NB in 0.15 M LiCl, followed by dual fluorescence staining with streptavidin–FITC and an antibody against Cx43 (red). Merged images show the extent of NB spread within the acini; n=10 acini. (D) Dual immunostaining of acini for Cx43 (red) and β-catenin (green; indicating cell–cell limits) in S1 cells treated as indicated. The peripheral organization of cells around a hollow center (left lower panel) is considered morphologically correct. Graph shows mean±s.e.m. percentages of acini with correct morphology; at least 100 acini analyzed per condition; n=3. (E) Dual immunostaining for Cx43 (red) and ZO-1 (green) in acini formed by S1 cells treated as indicated. The arrow points to the peripheral location of ZO-1 and the asterisk indicates the central location of a cell (optical section through the middle of the acinus), illustrating abnormal morphogenesis. Graph shows mean±s.e.m. percentages of acini with apical ZO-1 staining; at least 100 acini analyzed per condition; n=3. (F) Western blots show unchanged levels of total ZO-1 expression in 10-day-old S1 acini treated as indicated. Lamin B was used as loading control. (G,H) Western blots for Cx43 and co-immunoprecipitated β-catenin (G) or ZO-2 (H) following immunoprecipitation with Cx43 antibody in S1 acini. *P<0.05, **P<0.01, ***P<0.001; one way ANOVA, with Dunn's comparison (A,B), nonpaired t-test (D,E). Nuclei are counterstained with DAPI (blue). Scale bar: 10 µm.

    Journal: Journal of Cell Science

    Article Title: Connexin 43 maintains tissue polarity and regulates mitotic spindle orientation in the breast epithelium

    doi: 10.1242/jcs.223313

    Figure Lengend Snippet: Downregulation of Cx43 expression disrupts GJIC and apical polarity in S1 cells. (A) Western blot (upper image) and quantitative real-time PCR (bottom graph) for Cx43 expression in S1 cells following retroviral delivery of empty vector (EV) or non-specific sequence shRNA (NSS) used as negative controls, and Cx43-specific shRNA (shRNA). Lamin B serves as loading control; n=3. Cx43 mRNA expression normalized to EV control; data represented as mean±s.e.m. (B) Fluorescence immunostaining for Cx43 (red) in S1 cells treated as indicated and cultured for 10 days in 2D or 3D conditions. Arrows indicate Cx43 foci. Graph shows the mean±s.e.m. percentages of acini that express Cx43 in each treatment condition; at least 200 acini were analyzed per condition; n=3. (C) S1 cells infected with NSS (upper panel) or Cx43 shRNA (lower panel) were cultured in 3D for 10 days and microinjected with 3% NB in 0.15 M LiCl, followed by dual fluorescence staining with streptavidin–FITC and an antibody against Cx43 (red). Merged images show the extent of NB spread within the acini; n=10 acini. (D) Dual immunostaining of acini for Cx43 (red) and β-catenin (green; indicating cell–cell limits) in S1 cells treated as indicated. The peripheral organization of cells around a hollow center (left lower panel) is considered morphologically correct. Graph shows mean±s.e.m. percentages of acini with correct morphology; at least 100 acini analyzed per condition; n=3. (E) Dual immunostaining for Cx43 (red) and ZO-1 (green) in acini formed by S1 cells treated as indicated. The arrow points to the peripheral location of ZO-1 and the asterisk indicates the central location of a cell (optical section through the middle of the acinus), illustrating abnormal morphogenesis. Graph shows mean±s.e.m. percentages of acini with apical ZO-1 staining; at least 100 acini analyzed per condition; n=3. (F) Western blots show unchanged levels of total ZO-1 expression in 10-day-old S1 acini treated as indicated. Lamin B was used as loading control. (G,H) Western blots for Cx43 and co-immunoprecipitated β-catenin (G) or ZO-2 (H) following immunoprecipitation with Cx43 antibody in S1 acini. *P<0.05, **P<0.01, ***P<0.001; one way ANOVA, with Dunn's comparison (A,B), nonpaired t-test (D,E). Nuclei are counterstained with DAPI (blue). Scale bar: 10 µm.

    Article Snippet: For western blot analysis equal amounts of proteins were separated and immunoblotted with rabbit polyclonal antibodies against Cx43 (0.16 μg/ml; C6219 and 5 μg/ml; SAB4501175, Sigma-Aldrich; Ni et al., 2017 ), p-Akt (1:100; 9271, Cell Signaling Technology; Zhang et al., 2018 ), Akt (9272, 1:1000, Cell Signaling Technology; Geyer et al., 2018 ), β-catenin (0.04 μg/ml; sc7199, Santa Cruz Biotechnology; Nedvetsky et al., 2012 ); goat polyclonal antibody against ZO-2 (2 μg/ml, sc-8148, Santa Cruz Biotechnology; Talhouk et al., 2008 ); and monoclonal antibodies against Cx26 (0.5 μg/ml; 13-8100, Zymed Laboratories, San Francisco, CA), Cx43 (2 μg/ml; sc-271837, Santa Cruz Biotechnology; Lai et al., 2018 ) and ZO-1 (1 μg/ml; 33-9100, Life Technologies).

    Techniques: Expressing, Western Blot, Real-time Polymerase Chain Reaction, Plasmid Preparation, Sequencing, shRNA, Fluorescence, Immunostaining, Cell Culture, Infection, Staining, Immunoprecipitation